About PATHOVACS INC
PathoVacs is a biotechnology company focused on developing vaccines and diagnostics for infectious diseases, neurodegenerative disorders, and biothreat agents. Founded in 2009, the company leverages proprietary proteomics-based technology for biomarker discovery and offers contract research services.
Development of universal protein subunit vaccines for infectious agentsCreation of novel diagnostics for infectious and neurodegenerative diseasesContract protein biomarker discovery services for pathogensProprietary Proteomics-based Expression Library Screening (PELS) technology for antigen discovery
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $394K | |
| Federal contract award | Department of Defense | $976K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PATHOVACS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.